192 related articles for article (PubMed ID: 32956449)
1. Carvedilol induces biased β1 adrenergic receptor-nitric oxide synthase 3-cyclic guanylyl monophosphate signalling to promote cardiac contractility.
Wang Q; Wang Y; West TM; Liu Y; Reddy GR; Barbagallo F; Xu B; Shi Q; Deng B; Wei W; Xiang YK
Cardiovasc Res; 2021 Aug; 117(10):2237-2251. PubMed ID: 32956449
[TBL] [Abstract][Full Text] [Related]
2. cGMP catabolism by phosphodiesterase 5A regulates cardiac adrenergic stimulation by NOS3-dependent mechanism.
Takimoto E; Champion HC; Belardi D; Moslehi J; Mongillo M; Mergia E; Montrose DC; Isoda T; Aufiero K; Zaccolo M; Dostmann WR; Smith CJ; Kass DA
Circ Res; 2005 Jan; 96(1):100-9. PubMed ID: 15576651
[TBL] [Abstract][Full Text] [Related]
3. Phosphodiesterase 5 restricts NOS3/Soluble guanylate cyclase signaling to L-type Ca2+ current in cardiac myocytes.
Wang H; Kohr MJ; Traynham CJ; Ziolo MT
J Mol Cell Cardiol; 2009 Aug; 47(2):304-14. PubMed ID: 19345227
[TBL] [Abstract][Full Text] [Related]
4. Microdomain switch of cGMP-regulated phosphodiesterases leads to ANP-induced augmentation of β-adrenoceptor-stimulated contractility in early cardiac hypertrophy.
Perera RK; Sprenger JU; Steinbrecher JH; Hübscher D; Lehnart SE; Abesser M; Schuh K; El-Armouche A; Nikolaev VO
Circ Res; 2015 Apr; 116(8):1304-11. PubMed ID: 25688144
[TBL] [Abstract][Full Text] [Related]
5. Vasostatin-1 Stops Structural Remodeling and Improves Calcium Handling via the eNOS-NO-PKG Pathway in Rat Hearts Subjected to Chronic β-Adrenergic Receptor Activation.
Wang D; Shan Y; Huang Y; Tang Y; Chen Y; Li R; Yang J; Huang C
Cardiovasc Drugs Ther; 2016 Oct; 30(5):455-464. PubMed ID: 27595734
[TBL] [Abstract][Full Text] [Related]
6. sGC{alpha}1 mediates the negative inotropic effects of NO in cardiac myocytes independent of changes in calcium handling.
Cawley SM; Kolodziej S; Ichinose F; Brouckaert P; Buys ES; Bloch KD
Am J Physiol Heart Circ Physiol; 2011 Jul; 301(1):H157-63. PubMed ID: 21536853
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of type 5 phosphodiesterase counteracts β2-adrenergic signalling in beating cardiomyocytes.
Isidori AM; Cornacchione M; Barbagallo F; Di Grazia A; Barrios F; Fassina L; Monaco L; Giannetta E; Gianfrilli D; Garofalo S; Zhang X; Chen X; Xiang YK; Lenzi A; Pellegrini M; Naro F
Cardiovasc Res; 2015 Jun; 106(3):408-20. PubMed ID: 25852085
[TBL] [Abstract][Full Text] [Related]
8. GRK5 Controls SAP97-Dependent Cardiotoxic β
Xu B; Li M; Wang Y; Zhao M; Morotti S; Shi Q; Wang Q; Barbagallo F; Teoh JP; Reddy GR; Bayne EF; Liu Y; Shen A; Puglisi JL; Ge Y; Li J; Grandi E; Nieves-Cintron M; Xiang YK
Circ Res; 2020 Aug; 127(6):796-810. PubMed ID: 32507058
[TBL] [Abstract][Full Text] [Related]
9. Single L-type Ca(2+) channel regulation by cGMP-dependent protein kinase type I in adult cardiomyocytes from PKG I transgenic mice.
Schröder F; Klein G; Fiedler B; Bastein M; Schnasse N; Hillmer A; Ames S; Gambaryan S; Drexler H; Walter U; Lohmann SM; Wollert KC
Cardiovasc Res; 2003 Nov; 60(2):268-77. PubMed ID: 14613856
[TBL] [Abstract][Full Text] [Related]
10. Compartmentalization of cardiac beta-adrenergic inotropy modulation by phosphodiesterase type 5.
Takimoto E; Belardi D; Tocchetti CG; Vahebi S; Cormaci G; Ketner EA; Moens AL; Champion HC; Kass DA
Circulation; 2007 Apr; 115(16):2159-67. PubMed ID: 17420342
[TBL] [Abstract][Full Text] [Related]
11. Regulation of VASP phosphorylation in cardiac myocytes: differential regulation by cyclic nucleotides and modulation of protein expression in diabetic and hypertrophic heart.
Sartoretto JL; Jin BY; Bauer M; Gertler FB; Liao R; Michel T
Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1697-710. PubMed ID: 19734360
[TBL] [Abstract][Full Text] [Related]
12. Levosimendan prevents doxorubicin-induced cardiotoxicity in time- and dose-dependent manner: implications for inotropy.
Efentakis P; Varela A; Chavdoula E; Sigala F; Sanoudou D; Tenta R; Gioti K; Kostomitsopoulos N; Papapetropoulos A; Tasouli A; Farmakis D; Davos CH; Klinakis A; Suter T; Cokkinos DV; Iliodromitis EK; Wenzel P; Andreadou I
Cardiovasc Res; 2020 Mar; 116(3):576-591. PubMed ID: 31228183
[TBL] [Abstract][Full Text] [Related]
13. Carvedilol Selectively Stimulates βArrestin2-Dependent SERCA2a Activity in Cardiomyocytes to Augment Contractility.
Maning J; Desimine VL; Pollard CM; Ghandour J; Lymperopoulos A
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232617
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-133 modulates the β1-adrenergic receptor transduction cascade.
Castaldi A; Zaglia T; Di Mauro V; Carullo P; Viggiani G; Borile G; Di Stefano B; Schiattarella GG; Gualazzi MG; Elia L; Stirparo GG; Colorito ML; Pironti G; Kunderfranco P; Esposito G; Bang ML; Mongillo M; Condorelli G; Catalucci D
Circ Res; 2014 Jul; 115(2):273-83. PubMed ID: 24807785
[TBL] [Abstract][Full Text] [Related]
15. Intracellular β
Wang Y; Shi Q; Li M; Zhao M; Reddy Gopireddy R; Teoh JP; Xu B; Zhu C; Ireton KE; Srinivasan S; Chen S; Gasser PJ; Bossuyt J; Hell JW; Bers DM; Xiang YK
Circ Res; 2021 Jan; 128(2):246-261. PubMed ID: 33183171
[TBL] [Abstract][Full Text] [Related]
16. Pertussis toxin-sensitive G protein but not NO/cGMP pathway mediates the negative inotropic effect of carbachol in adult rat cardiomyocytes.
Sandirasegarane L; Diamond J
Pharmacology; 2004 Jan; 70(1):46-56. PubMed ID: 14646356
[TBL] [Abstract][Full Text] [Related]
17. Cardiac salvage by tweaking with beta-3-adrenergic receptors.
Balligand JL
Cardiovasc Res; 2016 Jul; 111(2):128-33. PubMed ID: 27001422
[TBL] [Abstract][Full Text] [Related]
18.
Wang J; Pani B; Gokhan I; Xiong X; Kahsai AW; Jiang H; Ahn S; Lefkowitz RJ; Rockman HA
Mol Pharmacol; 2021 Dec; 100(6):568-579. PubMed ID: 34561298
[No Abstract] [Full Text] [Related]
19. Heterologous desensitization of cardiac β-adrenergic signal via hormone-induced βAR/arrestin/PDE4 complexes.
Shi Q; Li M; Mika D; Fu Q; Kim S; Phan J; Shen A; Vandecasteele G; Xiang YK
Cardiovasc Res; 2017 May; 113(6):656-670. PubMed ID: 28339772
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of beta- but not alpha 1-mediated adrenergic responses in isolated hearts and cardiomyocytes by nitric oxide and 8-bromo cyclic GMP.
Ebihara Y; Karmazyn M
Cardiovasc Res; 1996 Sep; 32(3):622-9. PubMed ID: 8881523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
